GLP1R and metabolic dysfunction-associated steatotic liver disease: Our meta-analysis supports the efficacy of GLP-1 RAs (especially liraglutide and semaglutide) in improving NAFLD, as assessed by magnetic resonance-based techniques or liver histology.